Concentrix (NASDAQ:CNXC – Get Free Report) issued an update on its first quarter 2025 earnings guidance on Wednesday morning. The company provided earnings per share (EPS) guidance of 2.490-2.640 for the period, compared to the consensus estimate of 2.850. The company issued revenue guidance of $2.4 billion-$2.4 billion, compared to the consensus revenue estimate of $2.4 billion. Concentrix also updated its FY 2025 guidance to 11.180-11.770 EPS.
Concentrix Price Performance
NASDAQ CNXC opened at $47.47 on Thursday. Concentrix has a 1 year low of $36.28 and a 1 year high of $106.10. The company has a fifty day simple moving average of $43.25 and a 200 day simple moving average of $55.04. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 1.18. The company has a market cap of $3.08 billion, a P/E ratio of 15.41, a P/E/G ratio of 0.60 and a beta of 0.63.
Concentrix (NASDAQ:CNXC – Get Free Report) last released its quarterly earnings results on Wednesday, January 15th. The company reported $3.26 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.01 by $0.25. Concentrix had a net margin of 2.18% and a return on equity of 16.57%. The company had revenue of $2.45 billion during the quarter, compared to analysts’ expectations of $2.44 billion. During the same period in the prior year, the company earned $3.36 earnings per share. The business’s quarterly revenue was up 9.7% compared to the same quarter last year. On average, sell-side analysts predict that Concentrix will post 10.11 EPS for the current year.
Analyst Ratings Changes
View Our Latest Stock Report on Concentrix
About Concentrix
Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.
Featured Articles
- Five stocks we like better than Concentrix
- How to Invest in Small Cap StocksĀ
- 3 Defensive Stocks Analysts Are Bullish on to Kick Off the Year
- Basic Materials Stocks Investing
- Vistra Corp: Could 2025 Continue Its Streak of Outperformance?
- Most Volatile Stocks, What Investors Need to Know
- Vertex’s Pain Drug: Big Pharma’s Next Major Success?
Receive News & Ratings for Concentrix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concentrix and related companies with MarketBeat.com's FREE daily email newsletter.